The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tenofovir Disoproxil Fumarate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Tenofovir Disoproxil Fumarate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tenofovir Disoproxil Fumarate market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. HIV-1 Infection accounting for % of the Tenofovir Disoproxil Fumarate global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 30 Pcs/Box segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tenofovir Disoproxil Fumarate include Glaxo SmithKline, Gilead PHARMACARE, Chengdu Brilliant Pharmaceutical, CHIA TAI TIANQING (CTTQ) Pharmaceutical, and Anhui Biochem Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tenofovir Disoproxil Fumarate market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
30 Pcs/Box
10 Pcs/Box
Market segment by Application can be divided into
HIV-1 Infection
Chronic Hepatitis
Other
The key market players for global Tenofovir Disoproxil Fumarate market are listed below:
Glaxo SmithKline
Gilead PHARMACARE
Chengdu Brilliant Pharmaceutical
CHIA TAI TIANQING (CTTQ) Pharmaceutical
Anhui Biochem Pharmaceutical
Qilu Pharmaceutical
Cipla
Zydus Cadila
Dr Reddy's Laboratories
Mylan Pharmaceuticals
Natco Pharma
Emcure Pharmaceuticals
Torrent Pharmaceuticals
Wockhardt Ltd
Hetero Drugs
Abbott
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tenofovir Disoproxil Fumarate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tenofovir Disoproxil Fumarate, with price, sales, revenue and global market share of Tenofovir Disoproxil Fumarate from 2019 to 2022.
Chapter 3, the Tenofovir Disoproxil Fumarate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tenofovir Disoproxil Fumarate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tenofovir Disoproxil Fumarate market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tenofovir Disoproxil Fumarate.
Chapter 13, 14, and 15, to describe Tenofovir Disoproxil Fumarate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Tenofovir Disoproxil Fumarate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tenofovir Disoproxil Fumarate market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. HIV-1 Infection accounting for % of the Tenofovir Disoproxil Fumarate global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 30 Pcs/Box segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tenofovir Disoproxil Fumarate include Glaxo SmithKline, Gilead PHARMACARE, Chengdu Brilliant Pharmaceutical, CHIA TAI TIANQING (CTTQ) Pharmaceutical, and Anhui Biochem Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tenofovir Disoproxil Fumarate market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
30 Pcs/Box
10 Pcs/Box
Market segment by Application can be divided into
HIV-1 Infection
Chronic Hepatitis
Other
The key market players for global Tenofovir Disoproxil Fumarate market are listed below:
Glaxo SmithKline
Gilead PHARMACARE
Chengdu Brilliant Pharmaceutical
CHIA TAI TIANQING (CTTQ) Pharmaceutical
Anhui Biochem Pharmaceutical
Qilu Pharmaceutical
Cipla
Zydus Cadila
Dr Reddy's Laboratories
Mylan Pharmaceuticals
Natco Pharma
Emcure Pharmaceuticals
Torrent Pharmaceuticals
Wockhardt Ltd
Hetero Drugs
Abbott
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tenofovir Disoproxil Fumarate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tenofovir Disoproxil Fumarate, with price, sales, revenue and global market share of Tenofovir Disoproxil Fumarate from 2019 to 2022.
Chapter 3, the Tenofovir Disoproxil Fumarate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tenofovir Disoproxil Fumarate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tenofovir Disoproxil Fumarate market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tenofovir Disoproxil Fumarate.
Chapter 13, 14, and 15, to describe Tenofovir Disoproxil Fumarate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Tenofovir Disoproxil Fumarate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tenofovir Disoproxil Fumarate Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 30 Pcs/Box
1.2.3 10 Pcs/Box
1.3 Market Analysis by Application
1.3.1 Overview: Global Tenofovir Disoproxil Fumarate Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 HIV-1 Infection
1.3.3 Chronic Hepatitis
1.3.4 Other
1.4 Global Tenofovir Disoproxil Fumarate Market Size & Forecast
1.4.1 Global Tenofovir Disoproxil Fumarate Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Tenofovir Disoproxil Fumarate Sales in Volume (2017-2028)
1.4.3 Global Tenofovir Disoproxil Fumarate Price (2017-2028)
1.5 Global Tenofovir Disoproxil Fumarate Production Capacity Analysis
1.5.1 Global Tenofovir Disoproxil Fumarate Total Production Capacity (2017-2028)
1.5.2 Global Tenofovir Disoproxil Fumarate Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tenofovir Disoproxil Fumarate Market Drivers
1.6.2 Tenofovir Disoproxil Fumarate Market Restraints
1.6.3 Tenofovir Disoproxil Fumarate Trends Analysis
2 Manufacturers Profiles
2.1 Glaxo SmithKline
2.1.1 Glaxo SmithKline Details
2.1.2 Glaxo SmithKline Major Business
2.1.3 Glaxo SmithKline Tenofovir Disoproxil Fumarate Product and Services
2.1.4 Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Gilead PHARMACARE
2.2.1 Gilead PHARMACARE Details
2.2.2 Gilead PHARMACARE Major Business
2.2.3 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Product and Services
2.2.4 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Chengdu Brilliant Pharmaceutical
2.3.1 Chengdu Brilliant Pharmaceutical Details
2.3.2 Chengdu Brilliant Pharmaceutical Major Business
2.3.3 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
2.3.4 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical
2.4.1 CHIA TAI TIANQING (CTTQ) Pharmaceutical Details
2.4.2 CHIA TAI TIANQING (CTTQ) Pharmaceutical Major Business
2.4.3 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
2.4.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Anhui Biochem Pharmaceutical
2.5.1 Anhui Biochem Pharmaceutical Details
2.5.2 Anhui Biochem Pharmaceutical Major Business
2.5.3 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
2.5.4 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Qilu Pharmaceutical
2.6.1 Qilu Pharmaceutical Details
2.6.2 Qilu Pharmaceutical Major Business
2.6.3 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
2.6.4 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Tenofovir Disoproxil Fumarate Product and Services
2.7.4 Cipla Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Zydus Cadila
2.8.1 Zydus Cadila Details
2.8.2 Zydus Cadila Major Business
2.8.3 Zydus Cadila Tenofovir Disoproxil Fumarate Product and Services
2.8.4 Zydus Cadila Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Dr Reddy's Laboratories
2.9.1 Dr Reddy's Laboratories Details
2.9.2 Dr Reddy's Laboratories Major Business
2.9.3 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Product and Services
2.9.4 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Mylan Pharmaceuticals
2.10.1 Mylan Pharmaceuticals Details
2.10.2 Mylan Pharmaceuticals Major Business
2.10.3 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
2.10.4 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Natco Pharma
2.11.1 Natco Pharma Details
2.11.2 Natco Pharma Major Business
2.11.3 Natco Pharma Tenofovir Disoproxil Fumarate Product and Services
2.11.4 Natco Pharma Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Emcure Pharmaceuticals
2.12.1 Emcure Pharmaceuticals Details
2.12.2 Emcure Pharmaceuticals Major Business
2.12.3 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
2.12.4 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Torrent Pharmaceuticals
2.13.1 Torrent Pharmaceuticals Details
2.13.2 Torrent Pharmaceuticals Major Business
2.13.3 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
2.13.4 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Wockhardt Ltd
2.14.1 Wockhardt Ltd Details
2.14.2 Wockhardt Ltd Major Business
2.14.3 Wockhardt Ltd Tenofovir Disoproxil Fumarate Product and Services
2.14.4 Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Hetero Drugs
2.15.1 Hetero Drugs Details
2.15.2 Hetero Drugs Major Business
2.15.3 Hetero Drugs Tenofovir Disoproxil Fumarate Product and Services
2.15.4 Hetero Drugs Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Abbott
2.16.1 Abbott Details
2.16.2 Abbott Major Business
2.16.3 Abbott Tenofovir Disoproxil Fumarate Product and Services
2.16.4 Abbott Tenofovir Disoproxil Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Tenofovir Disoproxil Fumarate Breakdown Data by Manufacturer
3.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Tenofovir Disoproxil Fumarate Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Tenofovir Disoproxil Fumarate
3.4 Market Concentration Rate
3.4.1 Top 3 Tenofovir Disoproxil Fumarate Manufacturer Market Share in 2021
3.4.2 Top 6 Tenofovir Disoproxil Fumarate Manufacturer Market Share in 2021
3.5 Global Tenofovir Disoproxil Fumarate Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Tenofovir Disoproxil Fumarate Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tenofovir Disoproxil Fumarate Market Size by Region
4.1.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Region (2017-2028)
4.1.2 Global Tenofovir Disoproxil Fumarate Revenue by Region (2017-2028)
4.2 North America Tenofovir Disoproxil Fumarate Revenue (2017-2028)
4.3 Europe Tenofovir Disoproxil Fumarate Revenue (2017-2028)
4.4 Asia-Pacific Tenofovir Disoproxil Fumarate Revenue (2017-2028)
4.5 South America Tenofovir Disoproxil Fumarate Revenue (2017-2028)
4.6 Middle East and Africa Tenofovir Disoproxil Fumarate Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Type (2017-2028)
5.2 Global Tenofovir Disoproxil Fumarate Revenue by Type (2017-2028)
5.3 Global Tenofovir Disoproxil Fumarate Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Application (2017-2028)
6.2 Global Tenofovir Disoproxil Fumarate Revenue by Application (2017-2028)
6.3 Global Tenofovir Disoproxil Fumarate Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Tenofovir Disoproxil Fumarate Sales by Type (2017-2028)
7.2 North America Tenofovir Disoproxil Fumarate Sales by Application (2017-2028)
7.3 North America Tenofovir Disoproxil Fumarate Market Size by Country
7.3.1 North America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2017-2028)
7.3.2 North America Tenofovir Disoproxil Fumarate Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Tenofovir Disoproxil Fumarate Sales by Type (2017-2028)
8.2 Europe Tenofovir Disoproxil Fumarate Sales by Application (2017-2028)
8.3 Europe Tenofovir Disoproxil Fumarate Market Size by Country
8.3.1 Europe Tenofovir Disoproxil Fumarate Sales in Volume by Country (2017-2028)
8.3.2 Europe Tenofovir Disoproxil Fumarate Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Type (2017-2028)
9.2 Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Application (2017-2028)
9.3 Asia-Pacific Tenofovir Disoproxil Fumarate Market Size by Region
9.3.1 Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Tenofovir Disoproxil Fumarate Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Tenofovir Disoproxil Fumarate Sales by Type (2017-2028)
10.2 South America Tenofovir Disoproxil Fumarate Sales by Application (2017-2028)
10.3 South America Tenofovir Disoproxil Fumarate Market Size by Country
10.3.1 South America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2017-2028)
10.3.2 South America Tenofovir Disoproxil Fumarate Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Type (2017-2028)
11.2 Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Application (2017-2028)
11.3 Middle East & Africa Tenofovir Disoproxil Fumarate Market Size by Country
11.3.1 Middle East & Africa Tenofovir Disoproxil Fumarate Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Tenofovir Disoproxil Fumarate Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Tenofovir Disoproxil Fumarate and Key Manufacturers
12.2 Manufacturing Costs Percentage of Tenofovir Disoproxil Fumarate
12.3 Tenofovir Disoproxil Fumarate Production Process
12.4 Tenofovir Disoproxil Fumarate Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Tenofovir Disoproxil Fumarate Typical Distributors
13.3 Tenofovir Disoproxil Fumarate Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Tenofovir Disoproxil Fumarate Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Tenofovir Disoproxil Fumarate Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Glaxo SmithKline Basic Information, Manufacturing Base and Competitors
Table 4. Glaxo SmithKline Major Business
Table 5. Glaxo SmithKline Tenofovir Disoproxil Fumarate Product and Services
Table 6. Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Gilead PHARMACARE Basic Information, Manufacturing Base and Competitors
Table 8. Gilead PHARMACARE Major Business
Table 9. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Product and Services
Table 10. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Chengdu Brilliant Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Chengdu Brilliant Pharmaceutical Major Business
Table 13. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
Table 14. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. CHIA TAI TIANQING (CTTQ) Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. CHIA TAI TIANQING (CTTQ) Pharmaceutical Major Business
Table 17. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
Table 18. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Anhui Biochem Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Anhui Biochem Pharmaceutical Major Business
Table 21. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
Table 22. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Qilu Pharmaceutical Major Business
Table 25. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Product and Services
Table 26. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Cipla Basic Information, Manufacturing Base and Competitors
Table 28. Cipla Major Business
Table 29. Cipla Tenofovir Disoproxil Fumarate Product and Services
Table 30. Cipla Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 32. Zydus Cadila Major Business
Table 33. Zydus Cadila Tenofovir Disoproxil Fumarate Product and Services
Table 34. Zydus Cadila Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Dr Reddy's Laboratories Major Business
Table 37. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Product and Services
Table 38. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Pharmaceuticals Major Business
Table 41. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
Table 42. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Natco Pharma Major Business
Table 45. Natco Pharma Tenofovir Disoproxil Fumarate Product and Services
Table 46. Natco Pharma Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Emcure Pharmaceuticals Major Business
Table 49. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
Table 50. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Torrent Pharmaceuticals Major Business
Table 53. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Product and Services
Table 54. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Wockhardt Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Wockhardt Ltd Major Business
Table 57. Wockhardt Ltd Tenofovir Disoproxil Fumarate Product and Services
Table 58. Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 60. Hetero Drugs Major Business
Table 61. Hetero Drugs Tenofovir Disoproxil Fumarate Product and Services
Table 62. Hetero Drugs Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Abbott Basic Information, Manufacturing Base and Competitors
Table 64. Abbott Major Business
Table 65. Abbott Tenofovir Disoproxil Fumarate Product and Services
Table 66. Abbott Tenofovir Disoproxil Fumarate Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Tenofovir Disoproxil Fumarate Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 68. Global Tenofovir Disoproxil Fumarate Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Tenofovir Disoproxil Fumarate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Tenofovir Disoproxil Fumarate Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 71. Head Office and Tenofovir Disoproxil Fumarate Production Site of Key Manufacturer
Table 72. Tenofovir Disoproxil Fumarate New Entrant and Capacity Expansion Plans
Table 73. Tenofovir Disoproxil Fumarate Mergers & Acquisitions in the Past Five Years
Table 74. Global Tenofovir Disoproxil Fumarate Sales by Region (2017-2022) & (K Pcs)
Table 75. Global Tenofovir Disoproxil Fumarate Sales by Region (2023-2028) & (K Pcs)
Table 76. Global Tenofovir Disoproxil Fumarate Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Tenofovir Disoproxil Fumarate Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Tenofovir Disoproxil Fumarate Sales by Type (2017-2022) & (K Pcs)
Table 79. Global Tenofovir Disoproxil Fumarate Sales by Type (2023-2028) & (K Pcs)
Table 80. Global Tenofovir Disoproxil Fumarate Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Tenofovir Disoproxil Fumarate Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Tenofovir Disoproxil Fumarate Price by Type (2017-2022) & (USD/Pcs)
Table 83. Global Tenofovir Disoproxil Fumarate Price by Type (2023-2028) & (USD/Pcs)
Table 84. Global Tenofovir Disoproxil Fumarate Sales by Application (2017-2022) & (K Pcs)
Table 85. Global Tenofovir Disoproxil Fumarate Sales by Application (2023-2028) & (K Pcs)
Table 86. Global Tenofovir Disoproxil Fumarate Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Tenofovir Disoproxil Fumarate Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Tenofovir Disoproxil Fumarate Price by Application (2017-2022) & (USD/Pcs)
Table 89. Global Tenofovir Disoproxil Fumarate Price by Application (2023-2028) & (USD/Pcs)
Table 90. North America Tenofovir Disoproxil Fumarate Sales by Country (2017-2022) & (K Pcs)
Table 91. North America Tenofovir Disoproxil Fumarate Sales by Country (2023-2028) & (K Pcs)
Table 92. North America Tenofovir Disoproxil Fumarate Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Tenofovir Disoproxil Fumarate Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Tenofovir Disoproxil Fumarate Sales by Type (2017-2022) & (K Pcs)
Table 95. North America Tenofovir Disoproxil Fumarate Sales by Type (2023-2028) & (K Pcs)
Table 96. North America Tenofovir Disoproxil Fumarate Sales by Application (2017-2022) & (K Pcs)
Table 97. North America Tenofovir Disoproxil Fumarate Sales by Application (2023-2028) & (K Pcs)
Table 98. Europe Tenofovir Disoproxil Fumarate Sales by Country (2017-2022) & (K Pcs)
Table 99. Europe Tenofovir Disoproxil Fumarate Sales by Country (2023-2028) & (K Pcs)
Table 100. Europe Tenofovir Disoproxil Fumarate Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Tenofovir Disoproxil Fumarate Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Tenofovir Disoproxil Fumarate Sales by Type (2017-2022) & (K Pcs)
Table 103. Europe Tenofovir Disoproxil Fumarate Sales by Type (2023-2028) & (K Pcs)
Table 104. Europe Tenofovir Disoproxil Fumarate Sales by Application (2017-2022) & (K Pcs)
Table 105. Europe Tenofovir Disoproxil Fumarate Sales by Application (2023-2028) & (K Pcs)
Table 106. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2017-2022) & (K Pcs)
Table 107. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2023-2028) & (K Pcs)
Table 108. Asia-Pacific Tenofovir Disoproxil Fumarate Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Tenofovir Disoproxil Fumarate Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Type (2017-2022) & (K Pcs)
Table 111. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Type (2023-2028) & (K Pcs)
Table 112. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Application (2017-2022) & (K Pcs)
Table 113. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Application (2023-2028) & (K Pcs)
Table 114. South America Tenofovir Disoproxil Fumarate Sales by Country (2017-2022) & (K Pcs)
Table 115. South America Tenofovir Disoproxil Fumarate Sales by Country (2023-2028) & (K Pcs)
Table 116. South America Tenofovir Disoproxil Fumarate Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Tenofovir Disoproxil Fumarate Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Tenofovir Disoproxil Fumarate Sales by Type (2017-2022) & (K Pcs)
Table 119. South America Tenofovir Disoproxil Fumarate Sales by Type (2023-2028) & (K Pcs)
Table 120. South America Tenofovir Disoproxil Fumarate Sales by Application (2017-2022) & (K Pcs)
Table 121. South America Tenofovir Disoproxil Fumarate Sales by Application (2023-2028) & (K Pcs)
Table 122. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Region (2017-2022) & (K Pcs)
Table 123. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Region (2023-2028) & (K Pcs)
Table 124. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Type (2017-2022) & (K Pcs)
Table 127. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Type (2023-2028) & (K Pcs)
Table 128. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Application (2017-2022) & (K Pcs)
Table 129. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Application (2023-2028) & (K Pcs)
Table 130. Tenofovir Disoproxil Fumarate Raw Material
Table 131. Key Manufacturers of Tenofovir Disoproxil Fumarate Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Tenofovir Disoproxil Fumarate Typical Distributors
Table 135. Tenofovir Disoproxil Fumarate Typical Customers
List of Figures
Figure 1. Tenofovir Disoproxil Fumarate Picture
Figure 2. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Type in 2021
Figure 3. 30 Pcs/Box
Figure 4. 10 Pcs/Box
Figure 5. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Application in 2021
Figure 6. HIV-1 Infection
Figure 7. Chronic Hepatitis
Figure 8. Other
Figure 9. Global Tenofovir Disoproxil Fumarate Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 10. Global Tenofovir Disoproxil Fumarate Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Tenofovir Disoproxil Fumarate Sales (2017-2028) & (K Pcs)
Figure 12. Global Tenofovir Disoproxil Fumarate Price (2017-2028) & (USD/Pcs)
Figure 13. Global Tenofovir Disoproxil Fumarate Production Capacity (2017-2028) & (K Pcs)
Figure 14. Global Tenofovir Disoproxil Fumarate Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Tenofovir Disoproxil Fumarate Market Drivers
Figure 16. Tenofovir Disoproxil Fumarate Market Restraints
Figure 17. Tenofovir Disoproxil Fumarate Market Trends
Figure 18. Global Tenofovir Disoproxil Fumarate Sales Market Share by Manufacturer in 2021
Figure 19. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Manufacturer in 2021
Figure 20. Tenofovir Disoproxil Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Tenofovir Disoproxil Fumarate Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Tenofovir Disoproxil Fumarate Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Tenofovir Disoproxil Fumarate Sales Market Share by Region (2017-2028)
Figure 24. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Region (2017-2028)
Figure 25. North America Tenofovir Disoproxil Fumarate Revenue (2017-2028) & (USD Million)
Figure 26. Europe Tenofovir Disoproxil Fumarate Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Tenofovir Disoproxil Fumarate Revenue (2017-2028) & (USD Million)
Figure 28. South America Tenofovir Disoproxil Fumarate Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue (2017-2028) & (USD Million)
Figure 30. Global Tenofovir Disoproxil Fumarate Sales Market Share by Type (2017-2028)
Figure 31. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Type (2017-2028)
Figure 32. Global Tenofovir Disoproxil Fumarate Price by Type (2017-2028) & (USD/Pcs)
Figure 33. Global Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2028)
Figure 34. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Application (2017-2028)
Figure 35. Global Tenofovir Disoproxil Fumarate Price by Application (2017-2028) & (USD/Pcs)
Figure 36. North America Tenofovir Disoproxil Fumarate Sales Market Share by Type (2017-2028)
Figure 37. North America Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2028)
Figure 38. North America Tenofovir Disoproxil Fumarate Sales Market Share by Country (2017-2028)
Figure 39. North America Tenofovir Disoproxil Fumarate Revenue Market Share by Country (2017-2028)
Figure 40. United States Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Tenofovir Disoproxil Fumarate Sales Market Share by Type (2017-2028)
Figure 44. Europe Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2028)
Figure 45. Europe Tenofovir Disoproxil Fumarate Sales Market Share by Country (2017-2028)
Figure 46. Europe Tenofovir Disoproxil Fumarate Revenue Market Share by Country (2017-2028)
Figure 47. Germany Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Tenofovir Disoproxil Fumarate Revenue Market Share by Region (2017-2028)
Figure 56. China Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Tenofovir Disoproxil Fumarate Sales Market Share by Type (2017-2028)
Figure 63. South America Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2028)
Figure 64. South America Tenofovir Disoproxil Fumarate Sales Market Share by Country (2017-2028)
Figure 65. South America Tenofovir Disoproxil Fumarate Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Tenofovir Disoproxil Fumarate Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Tenofovir Disoproxil Fumarate Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Tenofovir Disoproxil Fumarate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Tenofovir Disoproxil Fumarate in 2021
Figure 77. Manufacturing Process Analysis of Tenofovir Disoproxil Fumarate
Figure 78. Tenofovir Disoproxil Fumarate Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
